Monitoring

Cryptococcal meningitis

  • Patients who have recovered from cryptococcal meningitis require careful follow-up for recurrence of symptoms.

  • Patients who are already diagnosed with HIV should continue their antiretroviral therapy. In treatment-naive HIV-infected patients with a recent diagnosis of cryptococcal meningitis, delaying antiretroviral therapy for 5 weeks was associated with improved survival compared with therapy initiation at 1 to 2 weeks, especially among patients with a paucity of white cells in cerebrospinal fluid (CSF).[106]

  • Treatment of cryptococcal meningitis in HIV-infected patients is complicated by the development of immune reconstitution inflammatory syndrome in nearly 1 in 8 patients.[19]

Histoplasmal meningitis[27]

  • CSF analysis should be repeated after 1 month, when liposomal amphotericin-B is replaced by an azole antifungal, and at 1 year, and if failure or relapse is suspected.

  • Therapy should be continued until CSF abnormalities have resolved and CSF antigen (and serum and urine antigen if initially positive) is negative.[72]

  • Serum and urine antigen, if initially positive, can be repeated at 2 weeks, 1 month, and then 3-monthly during therapy and for at least 6 months after treatment is terminated.

  • Patients in whom treatment failure or relapse is suspected should also have antigen levels measured.

Coccidioidal meningitis[11]

  • CSF analysis is repeated monthly initially.

  • If response is satisfactory, CSF is repeated 3-monthly for life.

  • Serum and CSF complement fixing-type antibodies decrease with successful therapy.

Candidal meningitis[75]

  • Due to the high rates of relapse in candidal meningitis, antifungal therapy must be given for a minimum of 4 weeks after resolution of all signs and symptoms.

  • All CSF analysis and radiologic findings should also normalize prior to stopping antifungal therapy.

Use of this content is subject to our disclaimer